Planned registrational trial of ganetespib in women with metastatic triple-negative breast cancer

Trial Profile

Planned registrational trial of ganetespib in women with metastatic triple-negative breast cancer

Planning
Phase of Trial: Phase III

Latest Information Update: 06 Aug 2013

At a glance

  • Drugs Ganetespib (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Aug 2013 This trial is expected to start in 2014, according to a Synta Pharmaceuticals media release.
    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top